We previously demonstrated that IPAS was involved in neurodegeneration in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced mouse model of Parkinson’s disease (PD), and degraded by activation of the PINK1-Parkin pathway4. The gene discussed is HIF3A; the disease is Parkinson disease.